This new investment supports BETA’s continued momentum certifying, producing and deploying all-electric aircraft and infrastructure, serving both commercial and military customers across cargo, ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

A major stride in battery science has unlocked a pathway that could accelerate solid-state innovation. A team, co-led by engineers at the University of California, San Diego, has unveiled a strategy ...

Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that ...

Read Seven Days’ November 5, 2025, cover story on Beta here. Vermont electric aviation startup Beta Technologies raked in more than $1 billion on Tuesday as it debuted on the New York Stock Exchange ...

In a change of pace, one company operating in the aerospace sector is expected to make its market debut today. Here’s what you need to know about Beta Technologies and its initial public offering: ...

Autoantibodies for type 1 diabetes are markers of the immune system’s attack on beta cells. Testing for these autoantibodies – GAD, IA-2, IAA, ZnT8, and ICA – can help with monitoring and preparing ...

Beta Technologies has a partnership with GE Aerospace IPO market reopens for high-growth startups Beta's aircraft used by US military and FAA Sept 29 (Reuters) - Electric aircraft maker Beta ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...

Two new studies point in opposite directions. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...